Abrdn Healthcare Investors (HQH)

HQH Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Other Revenue	7.53	10.77	10.29	8.27	6.48
Revenue	7.53	10.77	10.29	8.27	6.48
Revenue Growth (YoY)	-30.05%	4.64%	24.44%	27.63%	-27.46%
Gross Profit	7.53	10.77	10.29	8.27	6.48
Selling, General & Admin	10.75	10.99	11.48	11.94	12.71
Operating Expenses	10.75	10.99	11.48	11.94	12.71
Operating Income	-3.22	-0.22	-1.19	-3.67	-6.23
Currency Exchange Gain (Loss)	0	0	-0	0.01	-0.02
Other Non Operating Income (Expenses)	2.35	1.61	-	3.27	4.38
EBT Excluding Unusual Items	-0.87	1.39	-1.19	-0.39	-1.87
Gain (Loss) on Sale of Investments	99.48	183.56	57.52	-193.83	157.05
Pretax Income	98.61	184.95	56.33	-194.23	155.18
Net Income	98.61	184.95	56.33	-194.23	155.18
Net Income to Common	98.61	184.95	56.33	-194.23	155.18
Net Income Growth	-46.68%	228.30%	-	-	-35.67%
Shares Outstanding (Basic)	56	52	49	47	45
Shares Outstanding (Diluted)	56	52	49	47	45
Shares Change (YoY)	6.49%	5.44%	4.43%	4.22%	3.54%
EPS (Basic)	1.78	3.55	1.14	-4.10	3.42
EPS (Diluted)	1.78	3.55	1.14	-4.10	3.42
EPS Growth	-49.93%	211.37%	-	-	-37.87%
Dividend Per Share	2.240	2.040	1.610	1.830	2.010
Dividend Growth	9.80%	26.71%	-12.02%	-8.96%	12.92%
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-42.73%	-2.04%	-11.52%	-44.38%	-96.14%
Profit Margin	1309.02%	1717.36%	547.37%	-2348.38%	2394.57%
EBIT	-3.22	-0.22	-1.19	-3.67	-6.23
EBIT Margin	-42.73%	-2.04%	-11.52%	-44.38%	-96.14%
Revenue as Reported	7.53	10.77	10.29	8.27	6.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q